Fundraising Fox
/Companies
Sign in

Cyrano Therapeutics

Washington, US · Founded 2014 · Delaware corporation · 7 employees on LinkedIn · 4 known investors

Find your way into Cyrano Therapeutics

Sign up to see every warm intro you have to Cyrano Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cyrano Therapeutics team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Develops regenerative therapy for persistent smell loss, currently in Phase 2 clinical trials.

Healthtech

Founders & leadership

RG
Richard GeoffrionNamed on SEC filing
RH
Robert HenkinNamed on SEC filing

Board

GBGerry Brunk
Gerry BrunkBoard Of DirectorsManaging Director at Lumira Ventures
TK
Takahide KodaBoard director

Investors · 4

Remiges Ventures, Inc.listed by Remiges Ventures, Inc.Seattle

How we know: Remiges Ventures, Inc.'s portfolio page · funding news · refreshmiami.com · Not right? Tell us

DeepWork CapitalreportedOrlando

How we know: refreshmiami.com · Not right? Tell us

Florida Opportunity FundreportedOrlando

How we know: refreshmiami.com · Not right? Tell us

Funding

SEC filings, press & company announcements

$4.1M disclosed across 1 of 3 rounds · 2020–2025

▶$4.1MraisedNov 2020 · 11 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard GeoffrionExecutive Officer, Director
  • Gerry BrunkDirector
  • Takahide KodaDirector
  • Robert HenkinDirector
Offering amount
$12.8M
Amount sold
$4.1M
First sale
Nov 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Cyrano Therapeutics do?
Develops regenerative therapy for persistent smell loss, currently in Phase 2 clinical trials.
Who are Cyrano Therapeutics's investors?
Cyrano Therapeutics's investors include Lumira Ventures, Remiges Ventures, Inc., DeepWork Capital, Florida Opportunity Fund.
How much funding has Cyrano Therapeutics raised?
Cyrano Therapeutics has disclosed $4.1M raised across 1 of its 3 known rounds.
Where is Cyrano Therapeutics headquartered?
Cyrano Therapeutics is headquartered in Washington, US.